Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling
2021 · Molecular Therapy — Oncolytics · 31 citations
https://doi.org/10.1016/j.omto.2021.05.008
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
43
Citations
3
h-index
1
i10-index
Huayan Xie is an academic researcher from First Affiliated Hospital of Jinan University. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Epigenetics and DNA Methylation & Lung Cancer Treatments and Mutations. The author has an h-index of 3, co-authored 3 publications.
Click to start Chat